In an 80‑year‑old woman with lower lumbar pain, how often can corticosteroid injections be administered, and what anti‑inflammatory injection options are available for this region?

Steroid Injection Frequency and Types for Lower Lumbar Pain in an 80-Year-Old Woman

Based on the most recent high-quality evidence, I recommend AGAINST routine steroid injections for chronic lower lumbar pain in this patient, as the 2025 BMJ guideline provides a strong recommendation against these procedures due to uncertain efficacy and potential for serious harm, particularly relevant in an elderly patient. 1

However, if injections are being considered despite this recommendation, the evidence suggests limiting to no more than 4 injections per year at a given spinal level, with a minimum interval of 2-3 weeks between injections 2. In elderly patients like this 80-year-old woman, even greater caution is warranted due to increased risks of adverse effects including infection, altered consciousness, and in rare cases, paralysis or death 1.

Critical Context: Contradictory Guidelines

The evidence landscape is highly contradictory, which is important to understand:

• 2025 BMJ Guideline (highest quality, most recent): Provides strong recommendations AGAINST interventional procedures for chronic spine pain, stating "all or nearly all well-informed people would likely not want" these procedures 1

• 2020 NICE Guideline: States "do not offer spinal injections for managing low back pain" 1

• 2021 ACOEM Guideline: Recommends against lumbar epidural injections for chronic low back pain in the absence of significant radicular symptoms 1

However, other specialty society guidelines (ASPN 2022, ASIPP 2021) provide strong recommendations IN FAVOR of these same procedures 1, 3. This discrepancy exists because interventionalist-authored guidelines are three times more likely to report positive results than non-interventionalist guidelines 1.

Types of Anti-Inflammatory Injections for Lower Lumbar Pain

1. Epidural Steroid Injections (ESIs)

Three main approaches exist, with varying ventral epidural spread:

A. Transforaminal ESI (TF-ESI)

• Most effective route for targeted nerve root pathology 4, 5
• Delivers medication closest to the affected nerve root
• Best for single-level pathology (e.g., L5-S1 disc herniation)
• Higher risk of catastrophic complications including paralysis 1
• At 24 weeks: 30% complete relief, 53% partial relief 4

B. Interlaminar ESI (IL-ESI)

• Parasagittal interlaminar approach superior to midline 6
• Parasagittal: 89.7% ventral epidural spread vs. 31.7% midline 6
• At 6 months: 68.4% effective pain relief with parasagittal vs. 16.7% midline 6
• Appropriate for multilevel pathology
• Lower risk profile than transforaminal

C. Caudal ESI

• Safest approach with lowest complication risk
• Appropriate for multilevel stenosis or diffuse pathology
• Less targeted delivery, potentially less effective for focal lesions
• At 24 weeks: 3% complete relief, 53% partial relief 4

2. Facet Joint Interventions

A. Intra-articular Corticosteroid Injections

• Direct injection into facet joint
• Triamcinolone acetonide 40 mg typical dose 7
• VAS improvement from 7.6 to 4.1 at 6 months 7
• Limited evidence for sustained benefit; improvements may reflect placebo effect 7

B. Medial Branch Blocks (MBBs)

• 0.5 mL of 0.5% bupivacaine per targeted branch 7
• Primarily diagnostic tool before radiofrequency ablation
• Similar outcomes to intra-articular injections 7
• 2020 NICE recommends radiofrequency denervation ONLY after positive medial branch block 1

3. Sacroiliac Joint Injections

• For SI joint dysfunction contributing to lower back pain
• Local anesthetic with or without corticosteroid
• Should precede consideration of SI joint denervation/ablation

4. Trigger Point Injections

• Local anesthetic (with or without steroid) into myofascial trigger points
• 2021 ACOEM recommends local anesthetic only; glucocorticosteroids NOT recommended 1
• May be considered for chronic pain not resolving with exercise or NSAIDs

Steroid Selection and Dosing

Betamethasone provides superior and more prolonged pain relief compared to other steroids 5:

• Betamethasone: Greatest and most prolonged relief (preferred)
• Triamcinolone/Methylprednisolone: Similar initial relief, faster decline
• Dexamethasone: Lowest benefit traditionally, though new formulations (SP-102) show promise 8

Common dosing patterns 2:

• Dexamethasone: 10 mg most common (56% of practitioners)
• Particulate steroids (methylprednisolone): 80 mg most common for interlaminar injections (55%)
• 17% of practitioners use doses >80 mg, which may increase systemic effects in elderly patients

Critical Safety Considerations for This 80-Year-Old Patient

Age-Related Risks:

• Increased infection risk with immunosuppression from steroids
• Osteoporosis concerns with repeated corticosteroid exposure
• Glucose dysregulation if diabetic or pre-diabetic
• Cardiovascular effects from systemic steroid absorption
• Cognitive effects from altered consciousness (documented adverse effect) 1

Absolute Contraindications:

• Active infection at injection site
• Coagulopathy or anticoagulation (relative)
• Allergy to injectate

Monitoring Requirements:

• Blood glucose monitoring for 1-2 weeks post-injection
• Assessment for signs of infection
• Bone density consideration with repeated injections

Clinical Algorithm for Decision-Making

Step 1: Determine if radicular symptoms present

• If NO radicular symptoms: Do NOT offer epidural injections 1
• If YES: Proceed to Step 2

Step 2: Identify pain generator

• Disc herniation with radiculopathy: Consider transforaminal ESI (most effective but highest risk)
• Multilevel stenosis: Consider interlaminar (parasagittal approach) or caudal ESI
• Facet-mediated pain: Consider diagnostic medial branch block before any therapeutic intervention
• SI joint dysfunction: Consider SI joint injection

Step 3: Severity assessment

• Mild-moderate stenosis: Better response to ESI 5
• Severe stenosis: Significantly weaker pain relief; consider alternative management 5

Step 4: Conservative management trial FIRST

• Physical therapy, NSAIDs, activity modification
• Injections should NOT be first-line therapy

Step 5: If proceeding with injection

• Use betamethasone if available
• Limit to 4 injections/year maximum at same level 2
• Minimum 2-3 week intervals between injections
• Fluoroscopic guidance mandatory for safety

Common Pitfalls to Avoid

1. Using particulate steroids for cervical transforaminal injections: 10% of practitioners still do this despite guideline recommendations against it 2

2. Excessive injection frequency: 6% of practitioners allow >6 injections annually, 1% allow >10 2 - this increases cumulative steroid burden significantly

3. Injecting without radicular symptoms: Multiple guidelines recommend against this 1

4. Failing to consider that benefits are typically short-term: Most evidence shows 1-3 months of relief, not long-term resolution 1, 5

5. Not recognizing that severe stenosis responds poorly: Patients with severe stenosis have significantly weaker pain relief 5

Bottom Line for This 80-Year-Old Patient

Given her age and the 2025 BMJ strong recommendation against these procedures, prioritize non-interventional management. If her pain is truly refractory and she has clear radicular symptoms with imaging-confirmed pathology, a trial of epidural steroid injection may be considered with informed consent about limited evidence, short-term benefits, and potential harms. Limit to maximum 4 injections per year, use betamethasone if available, choose route based on pathology (transforaminal for single-level, interlaminar parasagittal or caudal for multilevel), and maintain heightened vigilance for complications given her age.